Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.5772/61320

Quantification of Cell-free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification

Patricia Diana Sørensen
Rikke Fredslund Andersen
Niels Pallisgaard
Jonna Skov Madsen
Erik Hugger Jakobsen
Ivan Brandslund


Puni tekst: engleski pdf 283 Kb

str. 4-9

preuzimanja: 282

citiraj


Sažetak

The purpose of this study was to quantify the free-circulating plasma HER-2 DNA (cfHER-2 DNA) and to assess the ability of analysis to discriminate between patients with primary breast cancer and healthy controls in order to detect metastatic recurrence in comparison with serum HER-2 protein and also HER-2 gene amplification.

The study population consisted of 100 patients with primary breast cancer and 50 healthy female donors. An additional 22 patients with metastases were subsequently included. cfHER-2 DNA was quantified with a quantitative PCR method together with a reference gene.

Results: Using a cut-off of 2.5 for the ratio of the cfHER-2 DNA/reference gene, three (of 15) tissue HER-2-positive patients had a ratio >2.5 prior to the detection of metastatic disease. In the post-metastatic/pre-chemotherapy setting, 11 (of 23) tissue HER-2-positive patients with metastases had a ratio >2.5.

There was no difference between absolute preoperative cfHER-2 DNA values for patients with primary breast cancer and those for healthy controls. There was no difference between cfHER-2 DNA values taken within nine months of development of the metastatic disease and the levels in patients without metastases, but there was a significant difference in the corresponding serum HER-2 protein levels in the tissue HER-2-positive patient group.

Conclusion: Amplified HER-2 DNA can be detected in plasma when using a ratio comparison between cfHER-2 DNA and a reference gene. cfHER-2 DNA could not be used to discriminate between patients with primary breast cancer and healthy controls, and could not predict the development of metastatic disease.

Ključne riječi

breast cancer; cell-free DNA; gene amplification; HER-2; metastatic recurrence; sensitivity

Hrčak ID:

161454

URI

https://hrcak.srce.hr/161454

Datum izdavanja:

1.1.2015.

Posjeta: 628 *